Cemiplimab for kidney organ transplant recipients with advanced cutaneous squamous cell carcinoma: CONTRAC-1.

被引：0
|
作者：
Hanna, Glenn J.
Dharaneeswaran, Harita J.
Giobbie-Hurder, Anita
Harran, John J.
Liao, Zixi
Pai, Lori
Tchekmedyian, Vatche
Ruiz, Emily S.
Waldman, Abigail H.
Schmults, Chrysalyne D.
Lizotte, Patrick H.
Paweletz, Cloud P.
Riella, Leonardo V.
Murakami, Naoka
Silk, Ann W.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Tufts Med Ctr, Boston, MA USA
[3] Maine Med Ctr, Portland, ME USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Brigham & Womens Faulkner Hosp, Boston, MA USA
[6] Belfer Ctr Appl Canc Sci, Boston, MA USA
[7] DFCI PCC Fellowship Program Attendings, Boston, MA USA
[8] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9519
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
    Hanna, Glenn J.
    Dharanesswaran, Harita
    Giobbie-Hurder, Anita
    Harran, John J.
    Liao, Zixi
    Pai, Lori
    Tchekmedyian, Vatche
    Ruiz, Emily S.
    Waldman, Abigail H.
    Schmults, Chrysalyne D.
    Riella, Leonardo V.
    Lizotte, Patrick
    Paweletz, Cloud P.
    Chandraker, Anil K.
    Murakami, Naoka
    Silk, Ann W.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (09) : 1021 - 1030
  • [2] Cemiplimab in advanced cutaneous squamous cell carcinoma
    Naik, Piyu Parth
    DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [3] Management of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients
    Lowenstein S.E.
    Garrett G.L.
    He S.Y.
    Mansh M.
    Arron S.T.
    Current Dermatology Reports, 2015, 4 (4) : 159 - 167
  • [4] The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients
    Harwood, C. A.
    Toland, A. E.
    Proby, C. M.
    Euvrard, S.
    Hofbauer, G. F. L.
    Tommasino, M.
    Bavinck, J. N. Bouwes
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : 1217 - 1224
  • [5] Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma
    Hernandez-Guerrero, T.
    Doger, B.
    Moreno, V
    DRUGS OF TODAY, 2019, 55 (08) : 485 - 494
  • [6] Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma
    Villani, Alessia
    Ocampo-Garza, Sonia Sofia
    Potestio, Luca
    Fabbrocini, Gabriella
    Ocampo-Candiani, Jorge
    Ocampo-Garza, Jorge
    Scalvenzi, Massimiliano
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 21 - 29
  • [7] Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma
    Lee, Arnold
    Duggan, Sean
    Deeks, Emma D.
    DRUGS, 2020, 80 (08) : 813 - 819
  • [8] Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus
    Gambichler, T.
    Hessam, S.
    Luettringhaus, T.
    Boms, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (03) : 608 - 609
  • [9] Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma
    Arnold Lee
    Sean Duggan
    Emma D. Deeks
    Drugs, 2020, 80 : 813 - 819
  • [10] Kidney transplant recipient with advanced cutaneous squamous cell carcinoma
    Wagner, Tristan
    Alakus, Hakan
    Stippel, Dirk
    ONKOLOGIE, 2024, 30 (07): : 626 - 627
12345